Quantitative characterization of changes in the cardiac mitochondrial proteome during anesthetic preconditioning and ischemia

Physiological Genomics

Volumn 45, Issue 5, 2013, Pages 163-170

  Bienengraeber, Martin ^a   Pellitteri Hahn, Molly ^a   Hirata, Naoyuki ^a   Baye, Tesfaye M ^a   Bosnjak, Zeljko J ^a   Olivier, Michael ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

18O labeling; Anesthetic preconditioning; Electron transport chain; Mitochondrial proteome

Indexed keywords

ISOFLURANE; MITOCHONDRIAL PROTEIN; OXYGEN 18;

ANESTHETIC INDUCED PRECONDITIONING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART MITOCHONDRION; ISCHEMIC PRECONDITIONING; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; REPERFUSION INJURY; RESPIRATORY CHAIN;

ANIMALS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; PROTEOME; RATS; RATS, WISTAR;

EID: 84874622571     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00117.2012     Document Type: Article

References (28)

1. Arrell DK, Elliott ST, Kane LA, Guo Y, Ko YH, Pedersen PL, Robinson J, Murata M, Murphy AM, Marban E, Van Eyk JE. Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res 99: 706-714, 2006.
2. Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL, Guo Y, Bolli R, Cardwell EM, Ping P. Protein kinase C epsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 92: 873-880, 2003.
3. Burwell LS, Nadtochiy SM, Brookes PS. Cardioprotection by metabolic shut-down and gradual wake-up. J Mol Cell Cardiol 46: 804-810, 2009.
4. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol 294: C460-C466, 2008.
5. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278: 36027-36031, 2003.
6. Ducret A, Van Oostveen I, Eng JK, Yates JR 3rd, Aebersold R. High throughput protein characterization by automated reverse-phase chromatography/ electrospray tandem mass spectrometry. Protein Sci 7: 706-719, 1998.
7. Feng J, Zhu M, Schaub MC, Gehrig P, Roschitzki B, Lucchinetti E, Zaugg M. Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function. Cardiovasc Res 80: 20-29, 2008.
8. Foster DB, Van Eyk JE, Marban E, O'Rourke B. Redox signaling and protein phosphorylation in mitochondria: progress and prospects. J Bioenerg Biomembr 41: 159-168, 2009.
9. Hall GM, Kirtland SJ, Baum H. The inhibition of mitochondrial respiration by inhalational anaesthetic agents. Br J Anaesth 45: 1005-1009, 1973.
10. Halligan BD, Slyper RY, Twigger SN, Hicks W, Olivier M, Greene AS. ZoomQuant: an application for the quantitation of stable isotope labeled peptides. J Am Soc Mass Spectrom 16: 302-306, 2005.
11. Hanley PJ, Ray J, Brandt U, Daut J. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol 544: 687-693, 2002.
12. Hicks WA, Halligan BD, Slyper RY, Twigger SN, Greene AS, Olivier M. Simultaneous quantification and identification using 18O labeling with an ion trap mass spectrometer and the analysis software application "ZoomQuant". J Am Soc Mass Spectrom 16: 916-925, 2005.
13. Hirata N, Shim YH, Pravdic D, Lohr NL, Pratt PF Jr, Weihrauch D, Kersten JR, Warltier DC, Bosnjak ZJ, Bienengraeber M. Isoflurane differentially modulates mitochondrial reactive oxygen species production via forward versus reverse electron transport flow: implications for preconditioning. Anesthesiology 115: 531-540, 2011.
14. Johansson JS, Zou H, Tanner JW. Bound volatile general anesthetics alter both local protein dynamics and global protein stability. Anesthesiology 90: 235-245, 1999.
15. Kalenka A, Maurer MH, Feldmann RE, Kuschinsky W, Waschke KF. Volatile anesthetics evoke prolonged changes in the proteome of the left ventricule myocardium: defining a molecular basis of cardioprotection? Acta Anaesthesiol Scand 50: 414-427, 2006.
16. Kevin LG, Novalija E, Riess ML, Camara AK, Rhodes SS, Stowe DF. Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg 96: 949-955, 2003.
17. Lee I, Bender E, Kadenbach B. Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase. Mol Cell Biochem 234-235: 63-70, 2002.
18. Ludwig LM, Weihrauch D, Kersten JR, Pagel PS, Warltier DC. Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. Anesthesiology 100: 532-539, 2004.
19. Matsuyama N, Leavens JE, McKinnon D, Gaudette GR, Aksehirli TO, Krukenkamp IB. Ischemic but not pharmacological preconditioning requires protein synthesis. Circulation 2000. 102: III312-III318,
20. Mirza SP, Olivier M. Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry. Physiol Genomics 33: 3-11, 2008.
21. Mueller LN, Brusniak MY, Mani DR, Aebersold R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J Proteome Res 7: 51-61, 2008.
22. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
23. Pratt PF Jr, Wang C, Weihrauch D, Bienengraeber MW, Kersten JR, Pagel PS, Warltier DC. Cardioprotection by volatile anesthetics: new applications for old drugs? Curr Opin Anaesthesiol 19: 397-403, 2006.
24. Pravdic D, Hirata N, Baber L, Sedlic F, Bosnjak ZJ, Bienengraeber M. Complex I and ATP synthase mediate membrane depolarization and matrix acidification by isoflurane in mitochondria. Eur J Pharmacol 690: 149-157, 2012.
25. Tanaka K, Weihrauch D, Kehl F, Ludwig LM, LaDisa JF Jr, Kersten JR, Pagel PS, Warltier DC. Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 97: 1485-1490, 2002.
26. 2+ pump: a potential mechanism for cytoprotection in heart and skeletal muscle. Appl Physiol Nutr Metab 33: 1023-1032, 2008.
27. Warltier DC, al-Wathiqui MH, Kampine JP, Schmeling WT. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 69: 552-565, 1988.
28. Wong R, Aponte AM, Steenbergen C, Murphy E. Cardioprotection leads to novel changes in the mitochondrial proteome. Am J Physiol Heart Circ Physiol 298: H75-H91, 2010.